SinglePoint to Add Leading Hemp CBD Product
from TorusMed to SingleSeed.com
Phoenix, AZ -- November 27,
2018 -- InvestorsHub NewsWire -- SinglePoint (OTCQB:SING)
a fully reporting technology company providing mobile payments,
ancillary cannabis services and blockchain solutions
announces that it
has entered into an agreement with TorusMed Inc., a subsidiary of
PetroSun
Inc. (OTCPINK:PSUD)
to
distribute TorusMed Hemp CBD products on two of their e-commerce
channels; SingleSeed.com and DIGSHydro.com. TorusMed will drop ship product
directly
to the
customers.
SinglePoint plans to have the
products on the site within the week and will provide an update
when ordering is live for the products.
The product line will include
Sport Relief Topical Cream which was designed for use
by
professional
and amateur
athletes.
Sport Relief is non-detect THC, meaning there are no traces of THC
in the topical, and triple-processed to make it our purest formula
yet. With non-detect, you can use this formula no matter what your
job or profession. Triple-processed means Sport Relief is miles
beyond the competition in the purity of the cannabinoids and
terpenes that your body is receiving. Sport Relief has no offensive
odor and will not stain clothes. Upon application, it creates
a pleasant sensation, with no oily or gritty feel to be
found.
TorusMed specializes in cutting-edge
technological advances in cultivation which produce world-renowned,
completely organic, full-plant extract tinctures and topical creams
for medical and home remedies. We are committed to the utmost
protection of every phase from seed to oil, providing the highest
quality, natural product at a price everyone can afford. With our
7-step purity process, cutting-edge cultivation and
extraction, TorusMed sets the standard of Hemp
extracts. We are inspired by the plant:
keep it pure, and the healing is pure. Our extracts contain no
contaminants; they are organic, non-GMO, and of the purest quality:
the way the plant is supposed to be. Grown for you.
Gordon LeBlanc, Jr., President of
TorusMed
states
"I am pleased to
announce our distribution deal with SinglePoint.
We have seen the
success SinglePoint has had through SingleSeed.com and believe
that TorusMed will be one of the best
sellers. TorusMed products have taken years to
develop in
partnerships with industry experts
and other
highly
qualified parties so we are confident
and believe that our products are one of the
best in the market."
"We are excited to add
TorusMeds' line of CBD products. We
have met the team and seen the glowing reviews
from TorusMed customers.
We
believe TorusMed and their suite of
products will provide additional
revenue for SinglePoint." commented Wil Ralston, President,
Singlepoint,
Inc.
TorusMed is currently working with
renowned doctors and a University to develop CBD that would
potentially be pharmaceutical grade. SinglePoint plans to
participate in this development with TorusMed and be a part of a new way of
facilitating the safe and repeated growth of specific strains of
CBD in a controlled environment.
The two sites, Singleseed.com
and DIGSHydro.com, are
subsidiaries of SING.
About
SinglePoint, Inc.
SinglePoint, Inc (SING)
is a technology and investment company with a focus on acquiring
companies that will benefit from the injection of growth capital
and technology integration. The company portfolio includes mobile
payments, ancillary cannabis services and blockchain solutions.
Through acquisitions into horizontal markets, SinglePoint is
building its portfolio by acquiring an interest in undervalued
companies, thereby providing a rich, diversified holding base.
Through SingleSeed, the company is providing
products and services to the cannabis industry.
Connect on
social media at:
https://www.facebook.com/SinglePointMobile
https://twitter.com/_SinglePoint
https://www.linkedin.com/company/singlepoint
For more
information visit: www.SinglePoint.com
Forward-Looking Statements
Certain statements in this
news release may contain forward-looking information within the
meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6
under the Securities Exchange Act of 1934, and are subject to the
safe harbor created by those rules. All statements, other than
statements of fact, included in this release, including, without
limitation, statements regarding potential future plans and
objectives of the Company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and actual results and
future events could differ materially from those anticipated in
such statements.
Technical complications,
which may arise, could prevent the prompt implementation of any
strategically significant plan(s) outlined above. The Company
undertakes no duty to revise or update any forward-looking
statements to reflect events or circumstances after the date of
this release.
Press Release disseminated
via OTC PR WIRE
Corporate
Communication
SinglePoint Inc.
855-711-2009
investors@SinglePoint.com
SinglePoint.com
